Skip to main content

Featured

HK backs sustainability reporting: CE

It is a great pleasure to be here, to have this welcome opportunity to speak to you, at the opening of the One Earth Summit.   The theme of this global gathering, “Planetary Crossroads: Investing in Innovations for a Sustainable Future”, highlights the importance of the challenges we face. For each and every one of us, for our families, companies and institutions, for the economies and countries we call home, for the world at large.   So it is reassuring to know that the speakers, as well as more than 500 attendees of this global summit, are internationally respected leaders and high-profile professionals in their fields. You have world-class expertise in the wide-ranging realm of sustainability, from finance and technology, to urban infrastructure and development, as well as agriculture, energy transition, new materials, industrial decarbonisation and more. Each of these sectors, and the critical challenges and boundless opportunities they present, are on today’s agenda, and w

1.7m vaccine doses given

About 1,704,400 doses of COVID-19 vaccines have been administered to the public, with about 1,055,500 people receiving their first dose and about 648,900 getting their second dose.   Among those given the first dose of vaccines, about 473,200 people have received the Sinovac jab and about 582,400 people have received the BioNTech one.   For the second dose, about 338,200 people have received the Sinovac vaccine, while about 310,700 people have been administered the BioNTech jab.   About 4,900 people received their first dose of the Sinovac vaccine under the COVID-19 Vaccination Programme today.   Among them, about 3,300 people received the jab at community vaccination centres (CVCs), while about 1,600 people were inoculated at private doctors and clinics participating in the programme.   Around 4,000 people received their second dose of the Sinovac vaccine today, including about 2,800 people vaccinated at CVCs and about 1,200 people through private doctors and clinics.   For the BioNTech vaccine, about 12,200 people received their first dose at CVCs and about 20,900 people received their second dose.   The overall percentage of people who received the Sinovac vaccine at CVCs is 96%, and that for the BioNTech one is 97%.   As of 8pm, about 2,700 people had booked their first and second doses of the Sinovac vaccine online, while about 8,600 had reserved their first and second doses of the BioNTech jab.   As of midnight, 16 people were sent to hospitals.
http://dlvr.it/RzLFv1

Popular Posts